Understanding lateral flow tests in a post-pandemic world

The COVID-19 pandemic has transformed the landscape of diagnostic testing, emphasizing the need for rapid, accurate, and accessible point-of-care solutions. Known for their simplicity and effectiveness, lateral flow tests use antibodies to detect specific antigens that indicate a certain disease or condition. Explore how the tests involve complex components and raw materials, with Merck providing technical and regulatory expertise in membrane choice and antibody development, ensuring consumer confidence in rapid test results.